Sumitomo Life Insurance Co. Lowers Stock Holdings in Danaher Corporation $DHR

Sumitomo Life Insurance Co. reduced its position in shares of Danaher Corporation (NYSE:DHR) by 6.4% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 6,955 shares of the conglomerate’s stock after selling 472 shares during the period. Sumitomo Life Insurance Co.’s holdings in Danaher were worth $1,374,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. MGO One Seven LLC increased its position in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares in the last quarter. Chicago Capital LLC increased its position in shares of Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares in the last quarter. UniSuper Management Pty Ltd increased its position in shares of Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. acquired a new stake in shares of Danaher during the first quarter worth about $539,000. Finally, ASR Vermogensbeheer N.V. increased its position in shares of Danaher by 1.9% during the second quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock worth $63,787,000 after purchasing an additional 6,136 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on DHR shares. Evercore ISI boosted their price target on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Guggenheim restated a “buy” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a research report on Friday, July 11th. Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Finally, TD Cowen boosted their price target on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Stock Performance

NYSE DHR opened at $215.63 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $203.41 and its two-hundred day moving average is $199.60. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The stock has a market capitalization of $152.31 billion, a price-to-earnings ratio of 44.46, a PEG ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the firm posted $1.71 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 26.39%.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.